Skip to content
Media Hub UK

The Zimbabwean Government Turns Down ‘One-Sided’ US Health Aid Package Over Information Apprehensions

Health funding illustration
The offered American funding was intended for initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has declined a major American health deal valued at $367m (£272m) over five years due to Washington's request for sensitive biological samples.

This move became public after a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa felt the deal was "skewed".

An official spokesman has since explained that the United States was seeking genetic material for research and profit while was unwilling to guarantee the resulting advantages from any future treatments.

"We must now begin the challenging and unfortunate task of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has urged continued negotiations to find a agreement suitable to both sides so the country's vital HIV programme can continue.

Wider Background

This rejection comes after a comparable case in neighbouring Kenya, where a court suspended a related deal with the US after legal challenges were filed about the security of citizens' medical information.

After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

USAID had overseen aid for the US government, but Trump argued its spending was "wasteful" and his government was pursuing government-to-government agreements to enhance transparency and responsibility.

As per reports, Sixteen nations in Africa have to date signed these new health pacts, representing over $18.3bn in new funding.

Details of the Rejected Deal

The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this cooperation might have yielded extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded programmes," the Ambassador said.

However, official spokesman Nick Mangwana argued the arrangement was "unequal".

"Zimbabwe was being asked to surrender its biological resources and data indefinitely, with no corresponding guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.

"Put simply, our country would provide the basic resources for scientific discovery without any assurance that the final treatments would be accessible to our citizens if a future health crisis emerge."

National Interest and International Frameworks

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were upending structures previously established through the global health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to deal with future global health emergencies.

"This framework is intended to guarantee that when a country contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to create them."

These objections regarding the US deal "must not be interpreted as hostility towards the US," he added.

"We encourage continued discussions with our US partners on how subsequent collaboration might be structured in a manner that respects the sovereignty and interests of each country."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but suggested that negotiations need to persist considering much of the nation's HIV programmes relied on international support.

"In cases where technical issues exist, including those relating to information security or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," the group commented.

The halted deal highlights the ongoing tensions between receiving crucial foreign assistance and safeguarding a country's data in an ever more interconnected world.

The writer

Mr. Donald Mcfarland

Elara is a multimedia journalist with over a decade of experience in digital media, specializing in tech innovation and cultural reporting.

Media Hub UK

Type to search articles.